Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. by Jaakkola, P, Mole, D, Tian, Y, Wilson, M, Gielbert, J, Gaskell, S, von Kriegsheim, A, Hebestreit, H, Mukherji, M, Schofield, C, Maxwell, P, Pugh, C, Ratcliffe, P

RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis by Tognoli, ML, Vlahov, N, Steenbeek, S, Grawenda, AM, Eyres, M, Cano-Rodriguez, D, Scrace, S, Kartsonaki, C, von Kriegsheim, A, Willms, E, Wood, MJ, O'Neill, E, Rots, MG, van Rheenen, J, Pankova, D

The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function by Mapperley, C, van de Lagemaat, LN, Lawson, H, Tavosanis, A, Paris, J, Campos, J, Wotherspoon, D, Durko, J, Sarapuu, A, Choe, J, Ivanova, I, Krause, DS, von Kriegsheim, A, Much, C, Morgan, M, Gregory, RI, Mead, AJ, O'Carroll, D, Kranc, KR

RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73. by Papaspyropoulos, A, Bradley, L, Thapa, A, Leung, C, Toskas, K, Koennig, D, Pefani, D, Raso, C, Grou, C, Hamilton, G, Vlahov, N, Grawenda, A, Haider, S, Chauhan, J, Buti, L, Kanapin, A, Lu, X, Buffa, F, Dianov, G, von Kriegsheim, A, Matallanas, D, Samsonova, A, Zernicka-Goetz, M, O'Neill, E

ALIX regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation by Monypenny, J, Milewicz, H, Flores-Borja, F, Weitsman, G, Cheung, A, Chowdhury, R, Burgoyne, T, Arulappu, A, Lawler, K, Barber, P, Vicencio, J, Keppler, M, Wulaningsih, W, Davidson, S, Fraternali, F, Woodman, N, Turmaine, M, Gillett, C, Franz, D, Quezada, S, Futter, C, Von Kriegsheim, A, Kolch, W, Vojnovic, B, Carlton, J, Ng, T